Q-Line Biotech IPO Live GMP Today
As of 28 May 2026, 08:35 pm IST, Q-Line Biotech SME IPO is quoting a grey market premium of +₹125 (+36.4% over the issue price), implying a listing around ₹468 per share.
| Status | Listed |
| Type | SME |
| Open Date | May 21, 2026 |
| Close Date | May 25, 2026 |
| Listing Date | May 29, 2026 |
| Lot Size | 800 shares |
| Issue Size | ₹214.00 Cr |
| Date | GMP (Rs) | GMP % | Est. Listing |
|---|---|---|---|
| May 28, 2026 08:35 pm | +125 | +36.4% | ₹468 |
| May 28, 2026 07:54 pm | +120 | +35.0% | ₹463 |
| May 28, 2026 07:43 am | +125 | +36.4% | ₹468 |
| May 27, 2026 08:18 pm | +115 | +33.5% | ₹458 |
| May 27, 2026 12:38 pm | +108 | +31.5% | ₹451 |
| May 26, 2026 07:35 pm | +104 | +30.3% | ₹447 |
| May 26, 2026 04:41 pm | +115 | +33.5% | ₹458 |
| May 25, 2026 03:07 pm | +99 | +28.9% | ₹442 |
| May 25, 2026 12:08 pm | +125 | +36.4% | ₹468 |
| May 23, 2026 10:34 am | +130 | +37.9% | ₹473 |
| May 22, 2026 09:45 am | +120 | +35.0% | ₹463 |
| May 21, 2026 09:57 pm | +132 | +38.5% | ₹475 |
| May 21, 2026 05:27 pm | +110 | +32.1% | ₹453 |
| May 21, 2026 04:15 pm | +125 | +36.4% | ₹468 |
| May 21, 2026 12:48 pm | +135 | +39.4% | ₹478 |
| May 21, 2026 07:36 am | +141 | +41.1% | ₹484 |
| May 20, 2026 07:59 pm | +100 | +29.2% | ₹443 |
| May 20, 2026 05:47 pm | +111 | +32.4% | ₹454 |
| May 20, 2026 01:40 pm | +112 | +32.7% | ₹455 |
| May 20, 2026 06:42 am | +110 | +32.1% | ₹453 |
| May 19, 2026 08:36 pm | +112 | +32.7% | ₹455 |
Q-Line Biotech IPO GMP — Detailed Analysis
What Q-Line Biotech GMP Tells Us Today
The current Grey Market Premium for Q-Line Biotech IPO is Rs 125 (36.4% over the issue price). Based on this GMP, the implied listing price hovers around Rs 468 per share. Across the 21 GMP records captured for this issue, the trend has been rising by Rs 13 — a useful directional signal for gauging investor sentiment as the listing date approaches.
How to Read the Q-Line Biotech GMP Trend
The GMP chart and history table above let you watch how unofficial demand has evolved through the bidding window. A few things worth noting when interpreting this data:
- Stable or rising GMP through bidding typically signals genuine investor demand and improves the odds of a positive listing day.
- A late-stage GMP spike (sudden jump only on the last day) is often speculative and tends to fade after listing — treat with caution.
- A declining GMP can signal either weakening sentiment or rational profit-booking by grey market players ahead of listing.
- GMP near zero or negative is a red flag — historically, IPOs that listed flat or in discount had GMP fizzle in the final days of bidding.
GMP Reliability for SME IPOs
SME IPO GMP is significantly more volatile than Mainboard GMP. Lower trading volume in the SME grey market and the smaller pool of dealers mean prices can swing sharply on small trades. Use SME GMP as a directional indicator rather than a precise price forecast — the actual listing price can deviate substantially from the implied GMP-based estimate, both upward and downward.
Q-Line Biotech IPO is expected to list on May 29, 2026. GMP signals between now and listing day are most useful as a real-time read on demand — final listing performance will also depend on subscription levels (especially QIB participation), fundamentals, and overall market conditions on the listing day.
For broader context on how GMP works as an indicator, see our explainer: What is IPO GMP?